Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04697901 · ClinicalTrials.gov registry record · NA
Sustaining Aviator Performance During Extended Operational Flight
A NA study of Transcranial Direct Current Stimulation, sponsored by United States Army Aeromedical Research Laboratory.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT04697901: Completed NA study of Transcranial Direct Current Stimulation, sponsored by United States Army Aeromedical Research Laboratory.
NCT04697901 is a NA study of Transcranial Direct Current Stimulation that has completed, run by United States Army Aeromedical Research Laboratory. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04697901, a NA study of Transcranial Direct Current Stimulation, has completed, sponsored by United States Army Aeromedical Research Laboratory.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Future aviation operations are anticipated to change as advances in technology enable automation of more tasks. Development of new platforms under the Future Vertical Lift program are also anticipated to change the nature of missions as they are being designed to cover further distances. Longer duration flights coupled with greater automated features are expected to shift the role of the aviator, resulting in an increased need for attention maintenance, which creates potential problems related to performance. To offset the likelihood of performance decrements related to the need to sustain attention, we propose examining the use of transcranial electrical current stimulation. In the present study, we will evaluate whether delivery of stimulation prior to or during the task enables sustainment of attention and thereby reduces performance decrements as measured through primary flight tasks and a secondary attentional task. Further, we will evaluate whether stimulation enhances the ability to respond to an unexpected emergency toward the end of the flight.
Primary Outcome
Cognitive function - sustained attention The RVIP is a well-validated measure of sustained attention (Bakan, 1959). In each trial, subjects are presented with a sequence of digits and must detect "target" sequences within those presented. The target sequence is an even-odd-even string of numbers. When participants detect this string, they press the spacebar as quickly as possible. Difficulty is manipulated by changing the speed at which the numbers are presented (1 vs. 2 seconds).
Conditions Studied
Interventions
- DEVICE Sham Transcranial Direct Current Stimulation (tDCS)
- DEVICE Active Transcranial Direct Current Stimulation (tDCS)
Study Locations (1)
Alabama
- U.S. Army Aeromedical Research Laboratory - Fort Rucker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
What the finished NCT04697901 record still lists
NCT04697901 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Transcranial Direct Current Stimulation appearing as the primary indexed condition, and to 2 interventions - of which Sham Transcranial Direct Current Stimulation (tDCS) is the first listed.
NCT04697901 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04697901 about?
NCT04697901 is a clinical study titled "Sustaining Aviator Performance During Extended Operational Flight". Future aviation operations are anticipated to change as advances in technology enable automation of more tasks. Development of new platforms under the Future Vertical Lift program are also anticipated to change the nature of missions as they are being designed to cover further distances. Longer dura...
What is the current status of trial NCT04697901?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-11-09. Estimated completion is 2021-09-30.
What conditions does trial NCT04697901 study?
This clinical trial studies the following conditions: Transcranial Direct Current Stimulation.
What interventions are being tested in trial NCT04697901?
The interventions under investigation include: Sham Transcranial Direct Current Stimulation (tDCS) (DEVICE), Active Transcranial Direct Current Stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT04697901?
This trial is sponsored by United States Army Aeromedical Research Laboratory, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04697901 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transcranial Direct Current Stimulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04697901's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI